Ectoparasiticides Market Size, Share, Growth, and Industry Analysis, By Type ( Injection, Spray ), By Application ( Pet, Livestock, Poultry ), Regional Insights and Forecast to 2035
1 Market Overview
1.1 Ectoparasiticides Product Introduction
1.2 Global Ectoparasiticides Market Size Forecast
1.3 Ectoparasiticides Market Trends & Drivers
1.3.1 Ectoparasiticides Industry Trends
1.3.2 Ectoparasiticides Market Drivers & Opportunity
1.3.3 Ectoparasiticides Market Challenges
1.3.4 Ectoparasiticides Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Ectoparasiticides Players Revenue Ranking (2023)
2.2 Global Ectoparasiticides Revenue by Company (2019-2024)
2.3 Key Companies Ectoparasiticides Manufacturing Base Distribution and Headquarters
2.4 Key Companies Ectoparasiticides Product Offered
2.5 Key Companies Time to Begin Mass Production of Ectoparasiticides
2.6 Ectoparasiticides Market Competitive Analysis
2.6.1 Ectoparasiticides Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Ectoparasiticides Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ectoparasiticides as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Injection
3.1.2 Spray
3.2 Global Ectoparasiticides Sales Value by Type
3.2.1 Global Ectoparasiticides Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Ectoparasiticides Sales Value, by Type (2019-2030)
3.2.3 Global Ectoparasiticides Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pet
4.1.2 Livestock
4.1.3 Poultry
4.2 Global Ectoparasiticides Sales Value by Application
4.2.1 Global Ectoparasiticides Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Ectoparasiticides Sales Value, by Application (2019-2030)
4.2.3 Global Ectoparasiticides Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Ectoparasiticides Sales Value by Region
5.1.1 Global Ectoparasiticides Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Ectoparasiticides Sales Value by Region (2019-2024)
5.1.3 Global Ectoparasiticides Sales Value by Region (2025-2030)
5.1.4 Global Ectoparasiticides Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Ectoparasiticides Sales Value, 2019-2030
5.2.2 North America Ectoparasiticides Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Ectoparasiticides Sales Value, 2019-2030
5.3.2 Europe Ectoparasiticides Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Ectoparasiticides Sales Value, 2019-2030
5.4.2 Asia Pacific Ectoparasiticides Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Ectoparasiticides Sales Value, 2019-2030
5.5.2 South America Ectoparasiticides Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Ectoparasiticides Sales Value, 2019-2030
5.6.2 Middle East & Africa Ectoparasiticides Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Ectoparasiticides Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Ectoparasiticides Sales Value
6.3 United States
6.3.1 United States Ectoparasiticides Sales Value, 2019-2030
6.3.2 United States Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Ectoparasiticides Sales Value, 2019-2030
6.4.2 Europe Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Ectoparasiticides Sales Value, 2019-2030
6.5.2 China Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.5.3 China Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Ectoparasiticides Sales Value, 2019-2030
6.6.2 Japan Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Ectoparasiticides Sales Value, 2019-2030
6.7.2 South Korea Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Ectoparasiticides Sales Value, 2019-2030
6.8.2 Southeast Asia Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Ectoparasiticides Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Ectoparasiticides Sales Value, 2019-2030
6.9.2 India Ectoparasiticides Sales Value by Type (%), 2023 VS 2030
6.9.3 India Ectoparasiticides Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Profile
7.1.2 Bayer Main Business
7.1.3 Bayer Ectoparasiticides Products, Services and Solutions
7.1.4 Bayer Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.1.5 Bayer Recent Developments
7.2 MSD Animal Health
7.2.1 MSD Animal Health Profile
7.2.2 MSD Animal Health Main Business
7.2.3 MSD Animal Health Ectoparasiticides Products, Services and Solutions
7.2.4 MSD Animal Health Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.2.5 MSD Animal Health Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Profile
7.3.2 Boehringer Ingelheim Main Business
7.3.3 Boehringer Ingelheim Ectoparasiticides Products, Services and Solutions
7.3.4 Boehringer Ingelheim Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.3.5 Ceva Sante Animale Recent Developments
7.4 Ceva Sante Animale
7.4.1 Ceva Sante Animale Profile
7.4.2 Ceva Sante Animale Main Business
7.4.3 Ceva Sante Animale Ectoparasiticides Products, Services and Solutions
7.4.4 Ceva Sante Animale Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.4.5 Ceva Sante Animale Recent Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Profile
7.5.2 Eli Lilly and Company Main Business
7.5.3 Eli Lilly and Company Ectoparasiticides Products, Services and Solutions
7.5.4 Eli Lilly and Company Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.5.5 Eli Lilly and Company Recent Developments
7.6 Zoetis, Inc.
7.6.1 Zoetis, Inc. Profile
7.6.2 Zoetis, Inc. Main Business
7.6.3 Zoetis, Inc. Ectoparasiticides Products, Services and Solutions
7.6.4 Zoetis, Inc. Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.6.5 Zoetis, Inc. Recent Developments
7.7 Sanofi
7.7.1 Sanofi Profile
7.7.2 Sanofi Main Business
7.7.3 Sanofi Ectoparasiticides Products, Services and Solutions
7.7.4 Sanofi Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.7.5 Sanofi Recent Developments
7.8 Virbac
7.8.1 Virbac Profile
7.8.2 Virbac Main Business
7.8.3 Virbac Ectoparasiticides Products, Services and Solutions
7.8.4 Virbac Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.8.5 Virbac Recent Developments
7.9 Vetoquinol S.A.
7.9.1 Vetoquinol S.A. Profile
7.9.2 Vetoquinol S.A. Main Business
7.9.3 Vetoquinol S.A. Ectoparasiticides Products, Services and Solutions
7.9.4 Vetoquinol S.A. Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.9.5 Vetoquinol S.A. Recent Developments
7.10 Dechra Pharmaceuticals Plc
7.10.1 Dechra Pharmaceuticals Plc Profile
7.10.2 Dechra Pharmaceuticals Plc Main Business
7.10.3 Dechra Pharmaceuticals Plc Ectoparasiticides Products, Services and Solutions
7.10.4 Dechra Pharmaceuticals Plc Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.10.5 Dechra Pharmaceuticals Plc Recent Developments
7.11 Advance Properties OOD/Huvepharma
7.11.1 Advance Properties OOD/Huvepharma Profile
7.11.2 Advance Properties OOD/Huvepharma Main Business
7.11.3 Advance Properties OOD/Huvepharma Ectoparasiticides Products, Services and Solutions
7.11.4 Advance Properties OOD/Huvepharma Ectoparasiticides Revenue (US$ Million) & (2019-2024)
7.11.5 Advance Properties OOD/Huvepharma Recent Developments
8 Industry Chain Analysis
8.1 Ectoparasiticides Industrial Chain
8.2 Ectoparasiticides Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Ectoparasiticides Sales Model
8.5.2 Sales Channel
8.5.3 Ectoparasiticides Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer





